Enovis Other Current Assets 2010-2024 | ENOV
Enovis other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Enovis Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2023 | $71 |
| 2022 | $48 |
| 2021 | $29 |
| 2020 | $113 |
| 2019 | $91 |
| 2018 | $1,135 |
| 2017 | $258 |
| 2016 | $326 |
| 2015 | $225 |
| 2014 | $297 |
| 2013 | $354 |
| 2012 | $282 |
| 2011 | $102 |
| 2010 | $87 |
| 2009 | $70 |
| Enovis Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $112 |
| 2024-06-30 | $87 |
| 2024-03-31 | $81 |
| 2023-12-31 | $71 |
| 2023-09-30 | $45 |
| 2023-06-30 | $75 |
| 2023-03-31 | $61 |
| 2022-12-31 | $48 |
| 2022-09-30 | $48 |
| 2022-06-30 | $34 |
| 2022-03-31 | $92 |
| 2021-12-31 | $29 |
| 2021-09-30 | $78 |
| 2021-06-30 | $76 |
| 2021-03-31 | $79 |
| 2020-12-31 | $113 |
| 2020-09-30 | $187 |
| 2020-06-30 | $156 |
| 2020-03-31 | $155 |
| 2019-12-31 | $91 |
| 2019-09-30 | $2,212 |
| 2019-06-30 | $2,294 |
| 2019-03-31 | $274 |
| 2018-12-31 | $1,135 |
| 2018-09-30 | $227 |
| 2018-06-30 | $213 |
| 2018-03-31 | $267 |
| 2017-12-31 | $258 |
| 2017-09-30 | $683 |
| 2017-06-30 | $253 |
| 2017-03-31 | $244 |
| 2016-12-31 | $326 |
| 2016-09-30 | $265 |
| 2016-06-30 | $264 |
| 2016-03-31 | $253 |
| 2015-12-31 | $225 |
| 2015-09-30 | $338 |
| 2015-06-30 | $321 |
| 2015-03-31 | $345 |
| 2014-12-31 | $297 |
| 2014-09-30 | $310 |
| 2014-06-30 | $355 |
| 2014-03-31 | $323 |
| 2013-12-31 | $354 |
| 2013-09-30 | $300 |
| 2013-06-30 | $298 |
| 2013-03-31 | $320 |
| 2012-12-31 | $282 |
| 2012-09-30 | $314 |
| 2012-06-30 | $322 |
| 2012-03-31 | $329 |
| 2011-12-31 | $102 |
| 2011-09-30 | $78 |
| 2011-06-30 | $80 |
| 2011-03-31 | $87 |
| 2010-12-31 | $87 |
| 2010-09-30 | $69 |
| 2010-06-30 | $68 |
| 2010-03-31 | $59 |
| 2009-12-31 | $70 |
| 2009-09-30 | $69 |
| 2009-06-30 | $62 |
| 2009-03-31 | $63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.608B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |